The inflammatory pathways, including JNK/AP-1 and IKK/NF-κB signaling, are activated in the process of MASLD induced by various factors including adipose tissue dysfunction, lipotoxicity, and endotoxins driven by the gut [64]. This evidence concerns the gene MAPK8 and metabolic dysfunction-associated steatotic liver disease.